Last reviewed · How we verify
2.5% benzoyl peroxide gel
At a glance
| Generic name | 2.5% benzoyl peroxide gel |
|---|---|
| Sponsor | Mahidol University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Experience With Topical Acne Treatment (EARLY_PHASE1)
- Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris (PHASE3)
- Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne (PHASE4)
- Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects (PHASE3)
- Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne (PHASE1, PHASE2)
- A Treatment for Severe Inflammatory Acne Subjects (PHASE4)
- A Study of Efficacy of Benzoyl Peroxide Regimens in Treatment of Unpleasant Foot Odor (PHASE4)
- Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 2.5% benzoyl peroxide gel CI brief — competitive landscape report
- 2.5% benzoyl peroxide gel updates RSS · CI watch RSS
- Mahidol University portfolio CI